Flow Cytometry Toxicology Applications
Total Trials
11
As Lead Sponsor
5
As Collaborator
6
Total Enrollment
7,126
NCT01697020
Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: Nov 30, 2012
NCT01929967
Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data
Phase: N/A
Role: Collaborator
Start: Aug 31, 2013
Completion: Jun 30, 2014
NCT02500680
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
Start: Jul 31, 2015
Completion: Dec 31, 2020
NCT03291080
Oral Liquid 13-cis-retinoic Acid (13-CRA)
Phase: Phase 1/2
Start: Apr 17, 2018
Completion: Sep 12, 2019
NCT03763656
Pharmacokinetics of Oral Hydroxyurea Solution
Start: Jan 3, 2019
Completion: Dec 29, 2021
NCT03930264
Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)
Start: Apr 11, 2019
Completion: May 31, 2019
NCT05067608
Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients
Start: Oct 25, 2019
Completion: Mar 24, 2021
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Phase: Phase 3
Start: Jul 13, 2020
Completion: Jun 30, 2033
NCT06119646
Warm Pads Applied to the Breast During Episiotomy Repair
Start: Jul 25, 2023
Completion: Aug 30, 2024
NCT06923111
PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]
Start: Jun 9, 2025
Completion: Jun 30, 2029
Loading map...